Arvee Laboratories (India) Ltd.
₹163.93
-1.2 (-0.7%)![]()
ARVEE Share Price
As on September 7, 2026
SectorChemicals
IndustryChemicals & Petrochemicals
Basic IndustrySpecialty Chemicals
Market Cap₹ 180 Cr
P/E Ratio84.13
Dividend YieldN/A
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open162.2
High169.15
NSE SymbolARVEE
Close163.93
Low162.2
BSE Symbol
Previous Years High/Low
1 Year High290.78
3 Year High315
5 Year High315
1 Year Low129.11
3 Year Low105.25
5 Year Low62.9
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 164.81 | Bearish |
| 10-DMA | 168.9 | Bearish |
| 20-DMA | 169.34 | Bearish |
| 50-DMA | 162.95 | Bullish |
| 100-DMA | 163.94 | Bearish |
| 200-DMA | 168.36 | Bearish |
Historical Performance
1 Year
7%
3 Years
51.8%
5 Years
70.8%
10 Years
N/A
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:11.3
3 Years:13.3
TTM:3.5
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 84.13, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered a moderate 3-year price CAGR of 13.3%, reflecting average market performance.
- The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
- In the last financial year, the company reported an EBITDA of ₹43 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹385 million, indicating a relatively small business scale.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1034911.6
No. of Shares: 6313 (Approx)
Performance:3.5%
34911.6
NIFTY Performance: -4%
1 day Top Gainers
| Symbol | Change% |
|---|---|
| SYRMA | 1634.8(12%) |
| WOCKPHARMA | 2208(6%) |
| HFCL | 243.01(5%) |
| IDEA | 15.6(4%) |
| SUPREMEIND | 3598(4%) |
1 Day Top Losers
| Symbol | Change% |
|---|---|
| HEG | 272.2(-63%) |
| ZEEL | 85.99(-6%) |
| PVRINOX | 1156.5(-6%) |
| ICICIPRULI | 470.65(-5%) |
| SAIL | 187.9(-5%) |
| MANAPPURAM | 325.6(-4%) |
| DEEPAKNTR | 1642.1(-4%) |
| SUNTV | 452.85(-4%) |
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed

Latest News
Stay Updated with Our Market Newsletters





